Lodge Hill Capital Lowered Eagle Materials (EXP) Stake; Cancer Genetics Has 0.62 Sentiment

July 17, 2017 - By Louis Casey

Lodge Hill Capital Llc decreased Eagle Materials Inc (EXP) stake by 36.9% reported in 2016Q4 SEC filing. Lodge Hill Capital Llc sold 225,000 shares as Eagle Materials Inc (EXP)’s stock declined 5.37%. The Lodge Hill Capital Llc holds 384,800 shares with $37.91 million value, down from 609,800 last quarter. Eagle Materials Inc now has $4.57 billion valuation. The stock rose 0.53% or $0.49 reaching $93.74. About 269,553 shares traded. Eagle Materials, Inc. (NYSE:EXP) has risen 36.20% since July 17, 2016 and is uptrending. It has outperformed by 19.50% the S&P500.

Cancer Genetics, Inc. is a United States company, which is engaged in the field of personalized medicine. The company has market cap of $74.61 million. The Firm offers diagnostic services and products that enable precision medicine in the field of oncology through molecular markers and diagnostics. It currently has negative earnings. The Firm offers a range of laboratory services that provide genomic and biomarker information.

About 63,671 shares traded. Cancer Genetics Inc (CGIX) has risen 81.82% since July 17, 2016 and is uptrending. It has outperformed by 65.12% the S&P500.

Since January 1, 0001, it had 3 insider purchases, and 0 sales for $457,563 activity.

Analysts await Cancer Genetics Inc (NASDAQ:CGIX) to report earnings on August, 8. They expect $-0.16 earnings per share, up 42.86% or $0.12 from last year’s $-0.28 per share. After $-0.11 actual earnings per share reported by Cancer Genetics Inc for the previous quarter, Wall Street now forecasts 45.45% negative EPS growth.

Perkins Capital Management Inc holds 1.28% of its portfolio in Cancer Genetics Inc for 863,600 shares. Diker Management Llc owns 36,815 shares or 0.02% of their US portfolio. Moreover, Sabby Management Llc has 0.01% invested in the company for 71,971 shares. The North Carolina-based Bank Of America Corp De has invested 0% in the stock. Barclays Plc, a United Kingdom-based fund reported 454 shares.

Analysts await Eagle Materials, Inc. (NYSE:EXP) to report earnings on July, 27 before the open. They expect $1.17 EPS, up 25.81% or $0.24 from last year’s $0.93 per share. EXP’s profit will be $57.04M for 20.03 P/E if the $1.17 EPS becomes a reality. After $0.88 actual EPS reported by Eagle Materials, Inc. for the previous quarter, Wall Street now forecasts 32.95% EPS growth.

Investors sentiment increased to 1.47 in 2016 Q4. Its up 0.36, from 1.11 in 2016Q3. It improved, as 28 investors sold EXP shares while 81 reduced holdings. 74 funds opened positions while 86 raised stakes. 43.96 million shares or 0.38% more from 43.79 million shares in 2016Q3 were reported. Ami Investment Mngmt owns 29,275 shares or 1.91% of their US portfolio. First Dallas has invested 1.52% in Eagle Materials, Inc. (NYSE:EXP). Sprucegrove Investment Mgmt Ltd holds 202,900 shares. Dynamic Capital Limited has invested 0.34% in Eagle Materials, Inc. (NYSE:EXP). M&T Bancorporation stated it has 0% in Eagle Materials, Inc. (NYSE:EXP). Jpmorgan Chase has invested 0.05% in Eagle Materials, Inc. (NYSE:EXP). Finemark Financial Bank And owns 403 shares. Tygh Cap Mngmt reported 58,289 shares stake. Alps Advsrs invested 0% in Eagle Materials, Inc. (NYSE:EXP). Leuthold Grp Ltd Liability Corporation has 8,811 shares for 0.1% of their portfolio. Holland Cap Ltd Company stated it has 0.1% of its portfolio in Eagle Materials, Inc. (NYSE:EXP). 13,000 were reported by Icon Advisers. California Public Employees Retirement System has invested 0.02% in Eagle Materials, Inc. (NYSE:EXP). Federated Invsts Pa holds 0.16% of its portfolio in Eagle Materials, Inc. (NYSE:EXP) for 555,975 shares. Fayez Sarofim reported 2,625 shares or 0% of all its holdings.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>